Increased incidence of cytogenetic abnormalities in chorionic villus samples from pregnancies established by in vitro fertilization and embryo transfer (IVF-ET) by Veld, P.A. (Peter) in't et al.
PRENATAL DIAGNOSIS, VOL. 15: 975-980 (1995) 
INCREASED INCIDENCE OF CYTOGENETIC 
ABNORMALITIES IN CHORIONIC VILLUS 
SAMPLES FROM PREGNANCIES ESTABLISHED 
BY IN VITRO FERTILIZATION AND EMBRYO 
TRANSFER (IVF-ET) 
P. A. I”T VELD, D. VAN OPSTAL, c. VAN DEN BERG, M. VAN OOIJEN, H. BRANDENBURG*, L. PIJPERS*$, 
Departments of Clinical Genetics, *Obstetrics and Gynaecology and ?Epidemiology and Biostatistics, 
University Hospital Dijkzigt and Erasmus University, Rotterdam; SMerwede Hospital, Dordrecht, 
The Netherlands 
M. G. J. JAHODA*, TH. STUNEN? AND F. J. LOS 
Received 9 January I995 
Revised 23 May 1995 
Accepted 18 June 1995 
SUMMARY 
We studied 201 pregnancies that were established by in vitro fertilization and embryo transfer (IVF-ET) and 
compared the frequency of cytogenetic abnormalities with that found in a large control population matched for 
indication group (advanced maternal age) and time of sampling. A total of 252 IVF-ET fetuses were cytogenetically 
analysed by either chorionic villus sampling (CVS; n=80) or amniocentesis (n= 172). Eleven chromosome 
abnormalities were found in the CVS group (13.8 per cent); among them, a 45,X/46,X,dic(Y)(ql1)/46,X,delCY)(qll) 
mosaic that was found in an IVF pregnancy established by intracytoplasmic sperm injection (ICSI), four cases of 
trisomy 21, and three cases of trisomy 7 confined to the placenta. The results indicate a statistically significant three- 
to five-fold increase in both confined placental abnormalities (P<0.008) and true fetal chromosome anomalies 
(W0.04). In the amniocentesis group, identical rates (1.7 per cent) of chromosome abnormalities were found in the 
IVF-ET and control groups. It is concluded that late first trimester, but not early second trimester, IVF-ET 
pregnancies are characterized by an increased frequency of cytogenetic abnormalities found at prenatal diagnosis. 
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INTRODUCTION 
The frequency of cytogenetic abnormalities in 
fetuses and neonates from pregnancies established 
by in vitro fertilization and embryo transfer (IVF- 
ET) has been the subject of a number of reports 
documenting birth defects in this population 
(AIHW, 1993; Rizk et al., 1991; Testart et al., 
1992). The frequency of unbalanced chromosome 
aberrations was found to be comparable to that 
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found in the general population and an IVF origin 
of pregnancy is generally not considered to be 
sufficient indication for invasive prenatal diag- 
nosis. However, IVF pregnancies are characterized 
by a high frequency of spontaneous abortions 
between 6 and 20 weeks of gestation (AIHW, 
1993), possibly indicating an increased frequency 
of cytogenetic abnormalities in the early IVF 
pregnancy, while very few studies are available 
that document prenatal findings in IVF popu- 
lations (Wiirfel ef al., 1992). We therefore 
performed a retrospective study to establish the 
incidence of cytogenetic abnormalities in IVF 
pregnancies of women referred for prenatal 
diagnosis because of advanced maternal age. 
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MATERIALS AND METHODS 
Between January 1990 and August 1994, a total 
of 201 women whose pregnancies were established 
by in vitro fertilization and embryo transfer (IVF- 
ET) at various centres in The Netherlands and 
Belgium were referred to our hospital for prenatal 
diagnosis because of advanced maternal age (2 36 
years at 18 weeks of pregnancy). One pregnancy 
was established by intracytoplasmic sperm injec- 
tion (ICSI) (Lanzendorf et aZ., 1988; Palermo 
et al., 1992) because of azoospermia; all the others 
were established by standard IVF procedures. The 
maternal age indication for prenatal diagnosis in 
the case of a donor oocyte was based on both the 
patient’s and the donor’s age. After appropriate 
counselling, 62 women opted for transabdominal 
chorionic villus sampling (TA-CVS) and 139 
women opted for amniocentesis. 
TA-CVS was performed at 11-14 weeks of ges- 
tation and 5-20mg of villi was obtained under 
ultrasound guidance (Jahoda ef al., 1990). Villi 
were incubated overnight using fluorodeoxyuridine 
(FdU) synchronization (Gibas et al., 1987). A total 
of 80 karyotypes were obtained from 46 single, 14 
twin, and 2 triplet pregnancies. 
Amniocentesis was performed at week 16-18 of 
gestation and 20 ml of amniotic fluid was aspirated 
under ultrasound guidance. Amniocytes were 
cultured in Chang medium on glass coverslips; 
in situ preparations were karyotyped after trypsin- 
Giemsa staining. A total of 172 karyotypes were 
obtained from 110 single, 25 twin, and 4 triplet 
pregnancies. 
The frequency of cytogenetic abnormalities in 
the IVF-ET population was compared with that in 
the control population consisting of pregnancies 
that were not established by IVF-ET and referred 
for prenatal diagnosis to our centre during the 
same period because of advanced maternal age. 
Control populations consisted of 4406 CVS and 
325 1 amniocenteses. Statistical analysis, in which 
the frequency of cytogenetic abnormalities in the 
various groups was compared for each age cat- 
egory, was carried out by the exact Mantel- 
Haenszel procedure. Odds ratios were corrected 
for both maternal age and gestational age in the 
CVS group. 
Fluorescent in situ hybridization (FISH) was 
performed on cultured amniocytes as described 
previously (Van Opstal et al., 1993). The following 
probes were applied: pDPlO5 (DYZ4) (Gal et al., 
1987) hybridizing to Yp; pDP97 (DYZ3) (Wolfe 
et al., 1985) hybridizing to the Y centromere; p49f 
(DY31) (Ngo el aZ., 1986) hybridizing to Yqll; 
and AmprobeRPN1305X (Lau, 1985) hybridizing 
to the heterochromatic part of Yq. 
RESULTS 
In chorionic villus biopsies from IVF-ET preg- 
nancies, a total of 11 cytogenetic abnormalities 
were found (excluding single cell aneuploidy and 
familial structural abnormalities), consisting of six 
fetal abnormalities and five confined placental 
mosaics (Table I). The fetal abnormalities com- 
prised a case of XYY and four cases of aneuploidy 
for chromosome 21; all four cases were ac- 
companied by echographic abnormalities (hydrops 
fetalis and/or hygroma colli) that were detected at 
the time of biopsy at 11-14 weeks of gestation. 
Two of these cases involved twin pregnancies 
which were selectively terminated. No material for 
confirmation of the fetal karyotype could be 
obtained from the selectively terminated cases. The 
single pregnancy that was established by intra- 
cytoplasmic sperm injection (ICSI) presented with 
a mosaic 45,X/46,X,dic(Y)(ql1)/46,X,del(Y)(qll) 
which was confirmed in amniotic fluid cells and 
fetal fibroblasts. Blood samples from both parents 
yielded normal karyotypes in 100 metaphases. The 
two derivative Y chromosomes (Fig. 1A) were 
characterized by FISH: both derivatives were 
negative with AmprobeRPN1305X and p49f indi- 
cating the absence of the heterochromatic region 
and substantial loss of euchromatin; probes 
pDPlO5 and pDP97 both showed two signals on 
the dic(Y)(qll) (Figs 1B and 1C) and one signal on 
the del(Y)(qll). The pregnancy was terminated at 
the parents’ request; obduction showed a male 
fetus without apparent congenital malformations. 
Comparison of the frequency of fetal cyto- 
genetic abnormalities in IVF pregnancies sampled 
by CVS (6/80; 7-5 per cent) with that in a control 
population (75/4406; 1.7 per cent) indicated a 
significant increase in the frequency of cytogenetic 
abnormalities in the IVF group (Pe0.04; odds 
ratio corrected for both maternal and gestational 
age 3.6; 95 per cent confidence interval 1.1-9.6). 
The five cases of confined placental mosaicism 
comprised one case in which both an additional 
chromosome 7 and an additional chromosome 13 
were present, two cases with trisomy 7, and two 
cases of sex chromosome mosaicism. In the control 
population a total of eight cases involving an 
CYTOGENETIC ABNORMALITIES IN IVF PREGNANCIES 977 
Table I-Xytogenetic abnormalities in chorionic villus samples from IVF-ET patients referred for advanced 
maternal age 
Gestational 
Case Age age 
No. (years) (weeks) Karyo type Follow-up 
Fetal abnormalities 
1* 37 13 
2* 36 12 
3* 38 12 
4 43 14 
5 39 12 
6 38 13 
Placental abnormalities 
7 39 12 
8* 38 12 
9 37 11 
10* 40 13 
11 35 11 
47,XY,+21 
4 7 , x w  
47,XX, + 2 1 
47,XY, +21 
46,XX/47,XX,+21 (U28) 
45,X/46,X,dic(Y)(ql1)/46,X,del(Y)(qll) 
(4/14/16) 
45,X/46,XY (1 2/22) 
46,XY/47,XY,+7/48,XY, + 7, + 13 (8/2/40) 
46,XY/47,XY,+7 (11/21) 
45,X/46,XX (2/18) 
47,XX,+7 
Selective TOP; NF 
Continued pregnancy 
Selective TOP; NF 
TOP; 47,XY,+21 (F) 
TOP; 47,XX,+21 (F) 
45,X/46,X,dic(Y)(q 11)/46,X,del(Y)(qll) 
TOP (AC; F) 
NF; normal boy 
46,XY (AC) 
46,XY (LTC; AC) 
46,XX (AC) 
46,XX (AC) 
~ ~ ~~ 
AC=Amniocentesis; LTC=long-term villus culture; F=fetal skin biopsy; TOP=termination of pregnancy; NF=no cytogenetic 
follow-up. An asterisk denotes a twin pregnancy; a nonnd karyotype was found by CVS in the second fetus, 
additional chromosome 7 were present. Compari- 
son of the frequency of all placental cytogenetic 
abnormalities (5/80; 6.2 per cent) with that in a 
control population (55/4406; 1.2 per cent) indi- 
cated a significant five-fold increase of placental 
cytogenetic abnormalities in the IVF population 
sampled by CVS (P<0.008; odds ratio corrected 
for both maternal and gestational age 5.6; 95 per 
cent confidence interval 1.615.2). 
In amniotic fluid samples obtained from 
IVF-ET pregnancies, a total of three cytogenetic 
abnormalities were found (excluding pseudo- 
mosaicism and familial structural abnormalities). 
All three cases involved trisomy 21 (Table 11). The 
frequency of non-familial cytogenetic abnormali- 
ties in the IVF population was 3/172 (1.7 per cent), 
which is identical (odds ratio corrected for mater- 
nal age 1.0; 95 per cent confidence interval 0.2-3.2) 
to the frequency in the control population of 
5613251 (1.7 per cent). 
DISCUSSION 
The present study documents cytogenetic abnor- 
malities in a population of 252 fetuses from preg- 
nancies of women referred for prenatal diagnosis 
because of advanced maternal age whose preg- 
nancy was established by in vitro fertilization and 
embryo transfer (IVF-ET). It compares the fre- 
quency of such abnormalities with that in a control 
population matched for indication group and 
period of sampling, and concludes that the fre- 
quency of cytogenetic abnormalities found in 
chorionic villi sampled at 11-14 weeks of gestation 
is significantly increased in the IVF-ET preg- 
nancies. In contrast, the frequency of such abnor- 
malities encountered after amniocentesis at 16-1 8 
weeks of gestation was found to be similar to that 
in the controls. 
Chromosome abnormalities found in chorionic 
villi can be divided into true fetal abnormalities 
and abnormalities confined to the placenta. A 
three- to four-fold higher frequency of fetal abnor- 
malities was found in the IVF-ET population: 
apart from four cases of trisomy 21 and a case of 
XYY, a complex chromosome mosaic 45,X/ 
46,X,dic(Y)(ql1)/46,X,de10r)(qll) was found in 
the single pregnancy that was established by intra- 
cytoplasmic sperm injection (ICSI). Combinations 
of XO and dicentric Yp or deleted Yq lines have 
been described previously, with patients presenting 
with a wide range of different phenotypes (Hsu, 
1994). Apart from the present finding, a total of 
five other chromosome aberrations have been 
described after ICSI (Bonduelle et al. , 1994). Inter- 
estingly, all the cases involve sex chromosome 
abnormalities, possibly indicating that the ICSI 
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Fig. ]-(A) Paternal Y chromosome (left) and fetal derivative Y chromo- 
somes (right) in a pregnancy established by intracytoplasmic sperm injection 
(ICSI) (GTG banding). (B) Partial metaphase with fluorescent in situ hybridiz- 
ation signals after hybridization with the Y centromere probe pDP97 and (C) 
the Yp probe pDPIOS showing two signals on both chromatids of the 
dic(Y)(qll) 
technique is associated with an increased preva- 
lence of sex chromosomal aberrations. As ICSI 
bypasses sperm selection and involves the injection 
of an entire spermatozoon into the ooplasm, it can 
be speculated that the increase is either due to the 
ICSI technique itself or is related to the (paternal) 
fertility problems which have led to the choice of 
ICSI as fertility treatment. 
The frequency of confined placental abnor- 
malities was found to be five-fold higher in the 
IVF-ET population sampled by CVS. Apart from 
two cases with a low-grade mosaic 45,X, three 
cases of trisomy 7 were found; both types of 
aneuploidy are a relatively common finding in 
CVS (Sachs et al., 1990), but the frequency of 
trisomy 7, either alone or in conjunction with 
another trisomy, was found to be 20-fold higher in 
the IVF-ET group than in the controls. The 
finding of (mosaic) trisomy 7 in a chorionic villus 
biopsy has not been reported to be associated with 
the presence of (mosaic) trisomy 7 in the fetus, but 
may be associated with a higher risk of cystic 
fibrosis (CF) through uniparental isodisomy from 
a mutation carrier (Spence et al., 1988). If an 
increased frequency of trisomy 7 placentae is not 
only present in classical IVF pregnancies, but is 
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Table II-Cytogenetic abnormalities in amniotic fluid samples from IVF-ET patients 
referred for advanced maternal age 
Gestational 
Case Age age 
No. (years) (weeks) Karyotype Follow up 
1* 41 16 47,xx, + 2 1 47,XX, + 2 1 (FB) 
2 40 18 47,XY, +21 TOP; NF 
3 39 16 46,XYl47,XY, +21 46,XY147,XY, +21 (F) 
Selective TOP 
(3128) (6/40); TOP 
FB=Fetal blood; F=fetal skin biopsy; NF=no cytogenetic follow-up; TOP= termination of 
pregnancy. An asterisk denotes a twin pregnancy; a normal karyotype was found after amniocentesis 
in the second fetus. 
also present after intracytoplasmic sperm injection 
(ICSI), this finding may be important as ICSI 
treatment is considered the fertility treatment of 
choice in males with congenital bilateral absence 
of the vasa deferentia (Devroey el al., 1994), a 
condition known to be associated with (com- 
pound) heterozygosity for mutations in the CF 
gene (Anguiano et al., 1992). 
In the IVF-ET group sampled by amniocentesis, 
the frequency of chromosome aberrations was not 
found to be different from that in a large control 
population; this contrasts with the finding in 
the IVF-ET group sampled by CVS in which 
marked differences with the controls were 
observed. Several factors may account for the 
different amniocentesis and CVS results: a high 
level (29 per cent) of spontaneous abortions was 
reported in the group of IVF pregnancies with a 
maternal age over 35 years (AIHW, 1993). The 
fetal cytogenetic abnormalities observed after 
CVS may thus represent pregnancies that would 
have aborted spontaneously before amniocentesis 
at 16 weeks of gestation. This possibility is sup- 
ported by the observation that all four cases of 
trisomy 21 found in this group showed hydrops 
fetalis and/or hygroma colli, conditions that, if 
the pregnancy had not been terminated at the 
parents’ request, might have led to a spontaneous 
abortion. Analysis of spontaneous abortions after 
IVF has documented chromosomally abnormal 
cases aborted between 11 and 16 weeks of ges- 
tation (Plachot, 1989). If an IVF pregnancy has 
an increased risk of a spontaneous abortion 
associated with a chromosome abnormality, it 
could be argued that prenatal diagnosis via 
amniocentesis at 16 weeks of gestation is the 
most suitable approach in these pregnancies 
(excluding the multiple gestations) as it would 
avoid unnecessary interventions. On the other 
hand, the increased risk of a confined placental 
abnormality argues in favour of CVS in those 
cases in which uniparental disomy, especially of 
chromosome 7, could be of importance, as it is in 
pregnancies at risk for cystic fibrosis. 
An alternative explanation for the difference 
between the amniocentesis and CVS groups 
may be found in the vanishing twin hypothesis 
(Tharapel et al., 1989), in which resorption of a 
co-twin results in a cytogenetically mixed placenta 
containing cells from both the continuing preg- 
nancy and the vanished twin. As IVF pregnancies 
are characterized by a high frequency of twin and 
triplet gestations, some of which spontaneously 
reduce to singleton and twin gestations, such a 
model may help to explain the increased frequency 
of placental anomalies found in CVS. However, in 
this model, discrepancies may be expected to occur 
between the sex established by CVS and that found 
after examination of fetal tissues; none has been 
found in the present series. The results of this 
retrospective study emphasize the continuing need 
for a close (cytogenetic) follow-up of pregnancies 
established by IVF-ET. 
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